Total Payments
$4,185
2024 Payments
$882.35
Companies
29
Transactions
245
Medicare Patients
12,364
Medicare Billing
$406,222
Payment Breakdown by Category
Food & Beverage$4,185 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,185 | 245 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $659.60 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $532.22 | 43 | $0 (2024) |
| Novo Nordisk Inc | $496.30 | 28 | $0 (2024) |
| PFIZER INC. | $439.21 | 24 | $0 (2024) |
| Amgen Inc. | $255.91 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $227.15 | 14 | $0 (2024) |
| Lilly USA, LLC | $223.26 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $149.05 | 9 | $0 (2023) |
| Astellas Pharma US Inc | $143.85 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $141.17 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $882.35 | 49 | GlaxoSmithKline, LLC. ($177.36) |
| 2023 | $1,389 | 84 | ABBVIE INC. ($224.08) |
| 2022 | $1,018 | 59 | ABBVIE INC. ($206.09) |
| 2021 | $895.26 | 53 | AbbVie Inc. ($200.01) |
All Payment Transactions
245 individual payment records from CMS Open Payments — Page 3 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Diabetes | ||||||
| 12/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Gastroenterology | ||||||
| 10/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes | ||||||
| 10/23/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Inflammation | ||||||
| 10/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PAIN | ||||||
| 10/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Diabetes | ||||||
| 10/03/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: UROLOGY | ||||||
| 09/28/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PAIN | ||||||
| 09/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: INSOMNIA | ||||||
| 09/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 2,838 | 3,940 | $273,607 | $95,808 |
| 2022 | 44 | 2,829 | 3,918 | $288,610 | $101,739 |
| 2021 | 42 | 3,371 | 4,557 | $318,093 | $112,450 |
| 2020 | 45 | 3,326 | 4,299 | $266,539 | $96,225 |
Total Patients
12,364
Total Services
16,714
Medicare Billing
$406,222
Procedure Codes
174
All Medicare Procedures & Services
174 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 304 | 481 | $127,253 | $34,147 | 26.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 112 | 112 | $29,851 | $11,971 | 40.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 267 | 401 | $10,739 | $5,261 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 286 | 430 | $9,082 | $4,451 | 49.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 305 | 524 | $8,981 | $4,402 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 204 | 265 | $8,904 | $4,362 | 49.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 32 | 33 | $13,875 | $4,256 | 30.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $8,033 | $3,936 | 49.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 285 | 448 | $6,962 | $3,409 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 46 | $8,597 | $2,465 | 28.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 29 | 30 | $4,307 | $2,141 | 49.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 60 | 65 | $3,848 | $1,886 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 112 | 171 | $3,321 | $1,628 | 49.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,769 | $1,510 | 40.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 36 | $2,318 | $1,089 | 47.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $6,236 | $1,055 | 16.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 56 | 63 | $1,900 | $931.14 | 49.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 36 | 36 | $1,390 | $681.12 | 49.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 38 | 49 | $1,336 | $654.64 | 49.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 14 | 15 | $1,238 | $606.75 | 49.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $1,030 | $483.84 | 47.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $1,096 | $436.16 | 39.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 50 | $1,533 | $417.15 | 27.2% |
| 83550 | Iron binding capacity | Office | 2023 | 35 | 46 | $804.08 | $394.22 | 49.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 54 | 60 | $693.60 | $339.60 | 49.0% |
About Stacey Stinger, ARNP
Stacey Stinger, ARNP is a Family healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2014. The National Provider Identifier (NPI) number assigned to this provider is 1619374451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Stinger, ARNP has received a total of $4,185 in payments from pharmaceutical and medical device companies, with $882.35 received in 2024. These payments were reported across 245 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,185).
As a Medicare-enrolled provider, Stinger has provided services to 12,364 Medicare beneficiaries, totaling 16,714 services with total Medicare billing of $406,222. Data is available for 4 years (2020–2023), covering 174 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Port Charlotte, FL
- Active Since 11/21/2014
- Last Updated 04/23/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1619374451
Products in Payments
- TRELEGY ELLIPTA (Drug) $395.97
- VRAYLAR (Drug) $312.00
- NURTEC ODT (Drug) $280.10
- Ozempic (Drug) $260.49
- XARELTO (Drug) $227.15
- Otezla (Drug) $192.92
- UBRELVY (Drug) $164.23
- XIFAXAN (Drug) $141.17
- SHINGRIX (Biological) $136.25
- ELIQUIS (Drug) $126.95
- Rybelsus (Drug) $124.49
- QULIPTA (Drug) $114.21
- Tymlos (Drug) $106.67
- NEXLETOL (Drug) $106.29
- ENTRESTO (Drug) $97.87
- COLOGUARD DNA CAPTURE REAGENTS (Device) $80.50
- EMGALITY (Drug) $75.98
- Veozah (Drug) $73.55
- Myrbetriq (Drug) $70.30
- GLASSIA (Biological) $64.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Port Charlotte
Annmarie Richardson, Arnp, ARNP
Family — Payments: $10,380
Family $10,380
Stacy Jean
Family — Payments: $7,814
Family $7,814
Monica Gomez, Aprn, APRN
Family — Payments: $4,929
Family $4,929
Rose Marie Mccafferty, Arnp, ARNP
Family — Payments: $4,117
Family $4,117
Jennifer Caluori, Arnp, ARNP
Family — Payments: $3,907
Family $3,907
Natalie Desantis, Aprn, APRN
Family — Payments: $3,298
Family $3,298